Stock Research: Stryker

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Stryker

NYSE:SYK US8636671013
96
  • Value
    53
  • Growth
    77
  • Safety
    Safety
    48
  • Combined
    74
  • Sentiment
    94
  • 360° View
    360° View
    96
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Stryker Corporation is a medical technology company that offers products and services to improve patient and healthcare outcomes. It operates in the MedSurg, Neurotechnology, and Orthopaedics industries. In the last fiscal year, the company had a market cap of $149,270 million, profits of $14,519 million, and revenue of $22,595 million, with 53,000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 96 (better than 96% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Stryker are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Stryker. The consolidated Growth Rank has a good rank of 77, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 77% of competitors in the same industry. The consolidated Safety Rank at 53 means that the company has a financing structure that is safer than 53% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 94, which means that professional investors are more optimistic about the stock than for 94% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 48, meaning that the share price of Stryker is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 52% of alternative stocks in the same industry. ...read more

more
Index
Dividends USA
Robotics
D.J. US Medical Equipment
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
48 43 49 91
Growth
77 63 65 63
Safety
Safety
53 41 26 23
Sentiment
94 88 96 94
360° View
360° View
96 70 84 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
70 54 48 24
Opinions Change
49 53 64 49
Pro Holdings
n/a 92 98 90
Market Pulse
95 95 95 97
Sentiment
94 88 96 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
48 43 49 91
Growth
77 63 65 63
Safety Safety
53 41 26 23
Combined
74 43 37 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
39 35 37 56
Price vs. Earnings (P/E)
17 17 23 48
Price vs. Book (P/B)
17 20 25 45
Dividend Yield
88 86 94 96
Value
48 43 49 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
52 55 39 21
Profit Growth
54 52 54 52
Capital Growth
70 47 78 80
Stock Returns
67 69 73 73
Growth
77 63 65 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
38 38 30 23
Refinancing
13 14 5 11
Liquidity
91 89 90 78
Safety Safety
53 41 26 23

Similar Stocks

Discover high‑ranked alternatives to Stryker and broaden your portfolio horizons.

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.